Want to see IN:ICRA full AI Analyst Report?
ICRA Limited (ICRA) AI Stock Analysis
ICRA Limited
(NSE:ICRA)
The overall score is driven primarily by ICRA’s excellent financial profile, combining strong profitability, low leverage, and consistently positive cash generation. Technical indicators show a soft price trend without severe downside momentum, tempering the otherwise robust fundamentals. Valuation appears reasonable for the quality of the business, supporting the score but not pushing it to the highest tier.
ICRA Limited (ICRA) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 41.41B
- Dividend Yield
- 2.44%
- Average Volume (3M)
- 1,401
- Price to Earnings (P/E)
- 21.2
- Beta (1Y)
- 0.95
- Revenue Growth
- 25.74%
- EPS Growth
- 10.32%
- Country
- India
- Employees
- 1,111
- Sector
- General
- Sector Strength
- 55
- Industry
- Financial - Data & Stock Exchanges
ICRA Limited Business Overview & Revenue Model
Company Description
ICRA Limited functions as an independent and professional firm specializing in investment information and credit ratings, operating both in India and internationally. Its activities are segmented into Rating, Research and Other Services; Consulting S...
ICRA Limited Financial Statement Overview
Summary
Financial performance is very strong, with revenue roughly doubling over six years, consistently high margins, low leverage, and steadily rising cash flows, despite some recent margin compression and cash flow volatility.
Income Statement
86Very PositiveBalance Sheet
93Very PositiveCash Flow
88Very Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.38B | 6.00B | 4.97B | 4.46B | 4.03B | 3.40B |
| Gross Profit | 1.96B | 1.87B | 2.44B | 1.83B | 1.96B | 1.75B |
| EBITDA | 2.74B | 2.83B | 2.55B | 2.24B | 1.92B | 1.61B |
| Net Income | 1.95B | 1.82B | 1.70B | 1.51B | 1.35B | 1.12B |
Balance Sheet | ||||||
| Total Assets | 0 | 14.86B | 12.94B | 11.87B | 11.01B | 9.78B |
| Cash, Cash Equivalents and Short-Term Investments | 8.07B | 7.69B | 10.51B | 5.75B | 5.03B | 3.70B |
| Total Debt | 0 | 184.01M | 131.35M | 126.83M | 130.28M | 140.26M |
| Total Liabilities | -11.85B | 3.01B | 2.37B | 2.06B | 1.46B | 1.31B |
| Stockholders Equity | 11.85B | 11.81B | 10.53B | 9.76B | 9.50B | 8.44B |
Cash Flow | ||||||
| Free Cash Flow | 730.71M | 1.65B | 1.32B | 1.00B | 901.70M | 921.54M |
| Operating Cash Flow | 779.99M | 1.77B | 1.45B | 1.07B | 992.58M | 973.75M |
| Investing Cash Flow | -436.88M | -1.30B | -168.90M | 274.94M | -768.39M | -718.62M |
| Financing Cash Flow | -607.27M | -667.00M | -1.03B | -1.37B | -321.26M | -320.29M |
ICRA Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ICRA, the sentiment is Negative. The current price of 4300.65 is below the 20-day moving average (MA) of 4438.76, below the 50-day MA of 4612.52, and below the 200-day MA of 5142.26, indicating a bearish trend. The MACD of -42.30 indicates Negative momentum. The RSI at 32.66 is Neutral, neither overbought nor oversold. The STOCH value of 32.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ICRA.
ICRA Limited Peers Comparison
Overall Rating
IN:CARERATING82Outperform
IN:ICRA80.15Outperform
IN:CRISIL77Outperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 82Outperform | INR 49.98B | 25.84 | ― | 1.33% | 18.86% | 25.69% | |
| 80Outperform | INR 41.51B | 21.20 | ― | 2.44% | 25.74% | 10.32% | |
| 77Outperform | INR 330.30B | 37.01 | ― | 1.42% | 23.83% | 19.56% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:ICRA | ICRA Limited | 4300.65 | -2091.66 | -32.72% | |
| IN:CARERATING | CARE Ratings Ltd | 1658.55 | 76.47 | 4.83% | |
| IN:CRISIL | CRISIL Limited | 4516.65 | -272.07 | -5.68% |
ICRA Limited Corporate Events
ICRA Releases Q2 and H1 FY2027 Investor Presentation
ICRA Limited, a prominent Indian credit rating and research firm, operates within the financial services sector, offering ratings and analytical insights to support investors, lenders and corporates in the capital markets. Its services underpin risk...
ICRA Schedules Q2 and H1 FY27 Earnings Call for November 4
ICRA Limited has scheduled an earnings conference call on November 4, 2026, to discuss its financial performance for the second quarter and first half of FY27 with investors and analysts. The call, accessible via domestic and international dial-in nu...
ICRA Files SEBI Dematerialisation Compliance Certificate for Q2 FY2026
ICRA Limited has submitted a certificate of compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, to BSE and NSE. The filing, supported by MUFG Intime India Private L...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 23, 2026